000			01962 a2200553 4500
005			20250517093153.0
264		0	_c20170509
008			201705s 0 0 eng d
022			_a1090-2430
024	7		_a10.1016/j.expneurol.2016.04.022 _2doi
040			_aNLM _beng _cNLM
100	1		_aPacini, Alessandra
245	0	0	_aThe α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. _h[electronic resource]
260			_bExperimental neurology _c08 2016
300			_a37-48 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtoxicity
650	0	4	_aBrain _xdrug effects
650	0	4	_aCalcium-Binding Proteins _xmetabolism
650	0	4	_aConotoxins _xtherapeutic use
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aGanglia, Spinal _xpathology
650	0	4	_aGlial Fibrillary Acidic Protein _xmetabolism
650	0	4	_aHyperalgesia _xdrug therapy
650	0	4	_aMale
650	0	4	_aMicrofilament Proteins _xmetabolism
650	0	4	_aNeuralgia _xchemically induced
650	0	4	_aNeuroglia _xdrug effects
650	0	4	_aNicotinic Antagonists _xtherapeutic use
650	0	4	_aOrganoplatinum Compounds _xtoxicity
650	0	4	_aOxaliplatin
650	0	4	_aPain Measurement
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReaction Time _xdrug effects
650	0	4	_aSpinal Cord _xmetabolism
650	0	4	_aTime Factors
700	1		_aMicheli, Laura
700	1		_aMaresca, Mario
700	1		_aBranca, Jacopo Juno Valerio
700	1		_aMcIntosh, J Michael
700	1		_aGhelardini, Carla
700	1		_aDi Cesare Mannelli, Lorenzo
773	0		_tExperimental neurology _gvol. 282 _gp. 37-48
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2016.04.022 _zAvailable from publisher's website
999			_c25976029 _d25976029